SPG3A-hereditary spastin paraplegia with genetic anticipation and incomplete penetrance

Chinese Journal of Medical Genetics

Volumn 24, Issue 1, 2007, Pages 15-18

  Ming, Lei ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Genetic anticipation; Hereditary spastin paraplegia; Incomplete penetrance; SPG3A gene

Indexed keywords

MEMBRANE PROTEIN; PROTEIN SPG3A; PROTEIN SPG6; SPASTIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PARENT; PENETRANCE; SEQUENCE ANALYSIS;

AGED; AGED, 80 AND OVER; ANTICIPATION, GENETIC; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GTP PHOSPHOHYDROLASES; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PENETRANCE; POLYMERASE CHAIN REACTION; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 33847261966     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fink JK. Hereditary spastic paraplegia: nine genes and counting. Arch Neurol,2003,60:1045-1049.
2. Fink JK. Hereditary spastic paraplegia. In: Rimoin D, Pyeritz RE, Connor J, et al. eds. Emery & Rimoin's principles and practice of medical genetics. 4th ed. London: Harcourt Publishers Limited, UK, 2002.3124-3145.
3. Zhao X, Alvarado D, Rainier S, et al. Mutations in a novel GTPase cause autosomal dominant hereditary spastic paraplegia. Nat Genet, 2001,29:326-331.
4. Hazan J, Lamy C, Melki J, et al. Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q. Nat Genet,1993,5:163-167.
5. Patemotte C, Rudnicki D, Fizames C, et al. Quality assessment of whole genome mapping data in the refined familial spastic paraplegia interval on chromosome 14q. Genome Res, 1998,8:1216-1227.
6. Gispert S, Santos N, Damen R, et al. Autosomal dominant familial spastic paraplegia: reduction of the FSP1 candidate region on chromosome 14q to 7 cM and locus heterogeneity. Am J Hum Genet, 1995,56:183-187.
7. Huang S, Zhuyu, Li H, et al. Another pedigree with pure autosomal dominant spastic paraplegia (AD-FSP) from Tibet mapping to 14q11.2-q24.3. Hum Genet, 1997,100:620-623.
8. Hentati A, Pericak-Vance MA, Lennon F, et al. Linkage of the late onset autosomal dominant familial spastic paraplegia to chromosome 2p markers. Hum Mol Genet, 1994,3:1867-1871.
9. Abel A, Fonknechten N, Hofer A, et al. Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A. Neurogenetics, 2004,239-243.
10. Muglia M, Magariello A, Nicoletti G, et al. Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia. Ann Neurol, 2002,51:794-795.
11. Tessa A, Casali C, Damiano M, et al. SPG3A: an additional family carrying a new atlastin mutation. Neurology, 2002,2002-2005.
12. Wilkinson PA, Hart PE, Patel H, et al. SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J Neurol Sci, 2003,216:4345.
13. Dalpozzo F, Rossetto MG, Boaretto MS, et al. Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation. Neurology, 2003,61:580-581.
14. Rainier S, Sher C, Reish O, et al. De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Arch Neurol, 2006,3:445-447.
15. Scarano V, Mancini P, Criscuolo C, et al. The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathy. J Neurol, 2005,8:901-903.
16. Sauter SM, Engel W, Neumann LM, et al. Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus. Hum Mutat, 2004,23:98.
17. Fonknechten N, Mavel D, Byrne P, et al. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet, 2000,9:637-644.
18. Hedera P, DiMauro S, Bonilla E, et al. Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q. Neurology, 1999,53:44-50.
19. D'Amico A, Tessa A, Sabino A, et al. Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene. Neurology, 2004,2138-2139.
20. Durr A, Camuzat A, Colin E, et al. Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol, 2004, 1867-1872.
21. Burger J, Metzke H, Patemotte C, et al. Autosomal dominant spastic paraplegia with anticipation maps to a 4-cM interval on chromosome 2p21-p24 in a large German family. Hum Genet, 1996,98:371-375.
22. Burger J, Fonknechten N, Hoeltzenbein M, et ed. Hereditary spastic paraplegia caused by mutations in the SPG4 gene. Eur J Hum Genet, 2000,8:771-776.
23. Thurmon TF, He C, Haskell C, et al. Genetic anticipation in a large family with pure autosomal dominant hereditary spastic paraplegia. Am J Med Genet, 2005,329-396.
24. Nielsen JE, Jensen S, Jennum P, et al. Autosomal dominant pure spastic paraplegia : a clinical, paraclinical, and genetic study. J Neural Neurosurg Psychiatry, 1998,64:61-66.
25. Raskind WH, Pericak-Vance MA, Lennon F, et al. Familial spastic paraparesis: evaluation of locus heterogeneity, anticipation, and haplotype mapping of the SPG4 locus on the short arm of chromosome 2. Am J Med Genet, 1997,74:26-36.
26. Fink JK, Heiman-Patterson T, Bird T, et al. Hereditary spastic paraplegia: advances in genetic research. Neurology, 1996,46:1507-1514.
27. Zhao X, Alvarado D, Rainier S, et al. Mutations in a novel newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet, 2001,29:326-331.
28. Svenson IK, Kloos M, Gaskell PC, et al. An intragenic modifier of hereditary spastic paraplegia due to spastin gene mutation suggests a role for cyclin-dependent kinase 5 in HSP pathogenesis. Neurogenetics, 2004,5:157-164.
29. Rainier S, Chai JH, Tokarz D, et al. NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet, 2003,73:967-971.